Baxter attracts Thermo Fisher, Celltrion as potential buyers for biopharma contracting business: Reuters
Remember Baxter’s Baxalta biopharmaceutical spinoff in 2015? The Illinois company is auctioning off businesses again and has reportedly attracted several suitors. | Baxter's contract manufacturing business has reportedly attracted interest from Thermo Fisher, Celltrion and several private equity groups as part of a bigger strategic overhaul.
What's Your Reaction?